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Retrospective diagnosis of X-linked hyper-IgM
syndrome in a family with multiple deaths of
affected males
All males in two generations of a Hungarian fam-
ily died of interstitial pneumonia. History and
records suggested X-linked hyper-IgM syndrome
(X-HIGM). DNA sequencing of a female carrier
revealed a c. 654C→A transversion of the CD40L
gene that predicts premature termination of CD40L
synthesis. This report points to the importance of
early carrier detection and genetic counseling in
families with X-linked primary immunodeficiency
diseases. We propose that the c.654C→A sequence
variant may associate with severe X-HIGM pheno-
type. 
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A 35-year old healthy but psychologically desperate
woman came to medical attention because of her bur-
dened family history (Figure; Patient III.3). She was
unaware of any consanguinity in the family, but all her
three brothers and two maternal uncles died of intersti-
tial pneumonia. In addition, eight maternal great-uncles
died of infectious diseases during the first decade of the
past century. Her mother and maternal aunt were
healthy, and had had no lymphoma or other hematolog-
ical malignancies. One of the proband’s brothers (Patient
III.4) was hospitalized 6-7 times a year with recurrent,
severe bacterial infections of the gastrointestinal and res-
piratory tracts until his death at age 10. Laboratory eval-
uations between 1971 and 1977 demonstrated severe
hypo-gammaglobulinemia with normal or elevated IgM
levels (IgG, 0.85-2.95 g/L; IgA, 0.10-0.87 g/L; IgM, 1.37-
3.72 g/L). These data together with the family history
suggested X-HIG.1-2
We performed mutational analysis of the CD40L of the
proband and her mother. The proband’s aunt (II.4) who
died at 70 years of age, and had no children, was not
available for genetic testing. Genomic DNA was isolated
from whole blood samples. Exons 1 to 5 of the CD40L,
and the flanking intron regions were amplified by PCR.3
The PCR products were sequenced with the BigDye
Terminator Cycle sequencing kit (Applied Biosystems).
DNA mutation numbering was based on the cDNA
sequence (GeneBank Accession No. L07414.1), and the
first nucleotide is the A of  the ATG translational initia-
tion codon. Genetic analysis revealed wild type
sequences of the proband, and heterozygosity for a
c.654C>A sequence variant resulting in premature termi-
nation of CD40L synthesis (p.C218X) in her mother
(Figure 1). These data confirmed that the deadly disease
in this family was X-HIGM due to CD40L deficiency.
Using these data proper genetic counseling was per-
formed.  
Retrospective diagnosis of primary immunodeficiency
diseases (PIDs) may be a professional and psychological
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Figure 1. Phenotype and genotype information. a, Clinical phenotypes of the patients and their relatives. Filled squares, male patients
with recurrent, severe infections; bars indicate they died. Patients II.1, II.3, III.1, and III.2 died of interstitial pneumonia at ages of 6, 12,
7, and 13 months, respectively. Patient III.4 presented with clinical and immunological phenotypes of X-HIGM, and died at 10 years of
age. b, Sequence analysis of the CD40L revealed wild type sequences in the proband, and heterozygosity for a c.654C→A nucleotide
substitution in her mother in exon 5; C, control. Mutation position is underlined. c, Amino acid sequence of the CD40L protein; in hem-
izygous patients the c.654C→A sequence variant is predicted to result in stop codon. 
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challenge in X-linked inherited disorders like X-HIGM,1, 2
X-linked lymphoproliferative disease,3 X-linked aγ−globu-
linemia,4 the Wiskott-Aldrich syndrome,5 Interleukin-2
receptor gene deficiency,6 or chronic granulomatous dis-
ease (gp91-phox deficiency).7 Our report describes a
unique life situation which may occur in families with X-
linked PID, and points to the importance of early muta-
tional analysis to define carriers, and to provide genetic
counseling and prenatal diagnosis. The p.C218X muta-
tion has been reported in 5 patients from three groups (8-
10). Our report and published data suggest that the recur-
rent c.654C>A sequence variant results in severe clinical
phenotype of X-HIGM. 
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ERRATA CORRIGE
In the article by Göran Carlsson, Andrew A.G. Aprikyan, Kim Göransdotter Ericson, Steve Stein, Vahagn Makaryan, David C. Dale, Magnus Nordenskjöld, Bengt Fadeel, Jan
Palmblad, Jan-Inge Hentera. Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemia
evolution in severe congenital neutropenia patients belonging to the original Kostmann family in northern Sweden published on Haematologica 2006;91:589-595 the
name of dr. Jan-Inge Henter was incorrectly written. Correct name should read Jan-Inge Henter instead of Jan-Inge Hentera. Our apologizes to the author.
In the article by Isidorins A, Tani M, Bonifazi F, Zinzani P, Curti A, Motta MR, Rizzi S, Giudice V, Farese O, Rovito M, Alinari L, Conte R, Baccarani M, Lemoli RM. Phase II
study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients published on
Haematologica 2005;90:225-31 the name of dr. Alessandro Isidori was incorrectly written. Correct name should read Alessandro Isidori instead of Alessandro Isidorins.
Our apologizes to the author.
